We further extended prior studies, reporting the protective effects of VPS35 overexpression against WT αSyn in the hippocampus of transgenic mice [28], to a well-characterized and robust rat model of PD based upon the AAV-mediated delivery of human WT αSyn [37, 41]. This evidence concerns the gene VPS35 and Parkinson disease.